Philips Healthcare has become the exclusive distributor of Corindus’ robotic-assisted CorPath 200 system, as on August 22, 2012, Philips announced its agreement with Corindus to distribute the interventional cardiology system in the US. Coronary artery disease (CAD) is the most common type of heart disease and is characterized by the buildup of plaque and narrowing of the coronary arteries. Over time, CAD weakens the heart muscle...
Yesterday, Los Angeles Superior Court Judge Michael Paul Linfield ruled that a lawsuit regarding Medtronic INFUSE Bone Grafts will take those injured by the medical product one step closer to having their day in court. The decision allows the lawsuit filed by a woman who experienced debilitating problems after having a surgery in which a Medtronic INFUSE Bone Graft was used in her neck to proceed.
Medtronic Receives FDA Approval, CE Mark for Arctic Front Advance(TM) Cardiac Cryoballoon to Treat Atrial FibrillationAugust 24, 2012 9:06 am | by The Associated Press | News | Comments
Next-Generation Technology Reinforces Safety and Efficacy While Improving Procedure Efficiency MINNEAPOLIS - Aug. 24, 2012 - Medtronic, Inc. (NYSE:MDT) today announced that its Arctic Front Advance(TM) Cardiac Cryoballoon has received...
Researchers develop a new blood-free, low-cost biosensor that detects blood glucose levels by sampling saliva, tears and urine. MASSDEVICE ON CALL — Researchers have developed a new blood-glucose sensor that doesn't need blood. The biosensor, developed at Purdue University, detects minute concentrations of glucose in saliva, tears and urine, and may be manufactured cheaply because it doesn't require many processing steps to produce, according to the researchers. News Well, Diabetes, On Callread more
AMSTERDAM & MEDINA, Ohio--(BUSINESS WIRE)--Aug 24, 2012--Tornier N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, today announced that it has signed a definitive agreement to acquire OrthoHelix Surgical Designs,...
Sapheon Completes First Closing in Series B Preferred Offering; Dr. Aaron Berez Joins Board of DirectorsAugust 24, 2012 1:51 am | by The Associated Press | News | Comments
SANTA ROSA, Calif.--(BUSINESS WIRE)--Aug 24, 2012--Sapheon Inc. has completed the first closing in its $18.5 million Series B Preferred equity offering. The Company issued 4,775,291 shares worth $8.6 million to Series B purchasers and convertible notes holders. The Company intends to use the...
After decades working in the medical device field, Scott Epstein, 55, of Boston is preparing to take pAguaMedicina, an FDA-approved pediatric ureteral stent, to market.
Tiny medical device maker Corindus Vascular Robotics has scored an A-list partner - the company announced that Royal Philips Electronics (NYSE: PHG, AEX: PHI) has agreed to distribute Corindus’ first FDA-approved product, a robotic-assisted system for the minimally invasive treatment of obstructed coronary arteries, which is known as percutaneous coronary intervention (PCI).
A federal appeals court has reversed a lower court decision in a patent dispute over a coronary stent involving Boston Scientific Corp. (NYSE: BSX), ruling that the lower court got it wrong when it ruled in favor of the Natick medical device giant.
Interleukin Genetics Inc. (OTCQB: ILIU) announced Friday that Lewis Bender resigned as CEO effective Thursday, and will be replaced by Kenneth Kornman, the company’s founder, president and chief scientific officer.
Healthcare informatics company eClinicalWorks is busting out of the seams of its existing Westborough location. The company said late Thursday that it paid $7.7 million for a 61,000-square-foot facility at 1 Technology Dr.
A pair of former ArthroCare senior executives are in the hot seat for their alleged roles in a securities fraud scheme that cost shareholders $400 million. Former ArthroCare (NSDQ:ARTC) senior executives John Raffle and David Applegate were arrested yesterday morning for alleged roles in a securities fraud scheme that cost shareholders more than $400 million. Legal News, News Well, Wall Street Beatread more
GI Dynamics CEO Stuart Randle tells MassDevice.com that the FDA's decision to let the company jump to a pivotal trial for its EndoBarrier weight loss device could speed up the medical device company's commercial launch in the U.S. A clearly elated Stu Randle told MassDevice.com today that the FDA's decision to allow GI Dynamics (ASX:GID) to skip directly to a pivotal trial for its EndoBarrier gastrointestinal liner represented a "huge milestone" for the medical device company. News Well, Bariatrics, FDAread more
CareFusion recalls more Alaris infusion pumps, the 3rd recall in as many months, prompting a 2% slide on Wall Street. CareFusion (NYSE:CFN) lost some points on Wall Street after the FDA slapped its latest infusion pump recall with Class I status, reserved for the most potentially dangerous device defects. CareFusion announced the 3rd recall in as many months, the 2nd affecting infusion pumps, after discovering issues with the keypad overlay on Alaris model 8100 infusion pump module door. News Well, Recallsread more
SHENZHEN, China, Aug. 23, 2012 /PRNewswire-Asia-FirstCall/ -- China Nepstar Chain Drugstore Ltd. (NYSE: NPD ) ("Nepstar" or the "Company"), the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the second quarter ended June 30, 2012. Financial Highlights Revenue increased by 1.8% to RMB617.6 millio...